Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa05205 | Proteoglycans in cancer | 196/6806 | 205/8135 | 0.0000000786 | 0.00000109 | 0.0000004 | 196 | RABC92 | |
| KEGG | hsa04062 | Chemokine signaling pathway | 184/6806 | 192/8135 | 0.000000111 | 0.00000148 | 0.00000054 | 184 | RABC92 | |
| KEGG | hsa04928 | Parathyroid hormone synthesis, secretion and action | 105/6806 | 106/8135 | 0.000000118 | 0.00000152 | 0.000000556 | 105 | RABC92 | |
| KEGG | hsa04152 | AMPK signaling pathway | 118/6806 | 120/8135 | 0.000000131 | 0.00000161 | 0.00000059 | 118 | RABC92 | |
| KEGG | hsa04510 | Focal adhesion | 192/6806 | 201/8135 | 0.000000137 | 0.00000163 | 0.000000596 | 192 | RABC92 | |
| KEGG | hsa04024 | cAMP signaling pathway | 210/6806 | 221/8135 | 0.000000144 | 0.00000166 | 0.000000605 | 210 | RABC92 | |
| KEGG | hsa04022 | cGMP-PKG signaling pathway | 161/6806 | 167/8135 | 0.000000175 | 0.00000195 | 0.000000714 | 161 | RABC92 | |
| KEGG | hsa04934 | Cushing syndrome | 150/6806 | 155/8135 | 0.000000193 | 0.00000208 | 0.00000076 | 150 | RABC92 | |
| KEGG | hsa04810 | Regulation of actin cytoskeleton | 207/6806 | 218/8135 | 0.000000214 | 0.00000223 | 0.000000816 | 207 | RABC92 | |
| KEGG | hsa04630 | JAK-STAT signaling pathway | 156/6806 | 162/8135 | 0.000000364 | 0.00000352 | 0.00000129 | 156 | RABC92 | |
| KEGG | hsa04371 | Apelin signaling pathway | 135/6806 | 139/8135 | 0.000000368 | 0.00000352 | 0.00000129 | 135 | RABC92 | |
| KEGG | hsa05162 | Measles | 135/6806 | 139/8135 | 0.000000368 | 0.00000352 | 0.00000129 | 135 | RABC92 | |
| KEGG | hsa04014 | Ras signaling pathway | 219/6806 | 232/8135 | 0.000000437 | 0.00000394 | 0.00000144 | 219 | RABC92 | |
| KEGG | hsa05171 | Coronavirus disease - COVID-19 | 219/6806 | 232/8135 | 0.000000437 | 0.00000394 | 0.00000144 | 219 | RABC92 | |
| KEGG | hsa04925 | Aldosterone synthesis and secretion | 97/6806 | 98/8135 | 0.000000466 | 0.0000041 | 0.0000015 | 97 | RABC92 | |
| KEGG | hsa05215 | Prostate cancer | 96/6806 | 97/8135 | 0.000000553 | 0.00000473 | 0.00000173 | 96 | RABC92 | |
| KEGG | hsa04015 | Rap1 signaling pathway | 199/6806 | 210/8135 | 0.00000061 | 0.0000051 | 0.00000186 | 199 | RABC92 | |
| KEGG | hsa05224 | Breast cancer | 142/6806 | 147/8135 | 0.000000636 | 0.00000518 | 0.00000189 | 142 | RABC92 | |
| KEGG | hsa04919 | Thyroid hormone signaling pathway | 118/6806 | 121/8135 | 0.000000911 | 0.00000725 | 0.00000265 | 118 | RABC92 | |
| KEGG | hsa04931 | Insulin resistance | 106/6806 | 108/8135 | 0.000000934 | 0.00000725 | 0.00000265 | 106 | RABC92 | |
| KEGG | hsa04142 | Lysosome | 128/6806 | 132/8135 | 0.00000107 | 0.00000811 | 0.00000297 | 128 | RABC92 | |
| KEGG | hsa04912 | GnRH signaling pathway | 92/6806 | 93/8135 | 0.00000109 | 0.00000811 | 0.00000297 | 92 | RABC92 | |
| KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 127/6806 | 131/8135 | 0.00000125 | 0.00000884 | 0.00000323 | 127 | RABC92 | |
| KEGG | hsa04722 | Neurotrophin signaling pathway | 116/6806 | 119/8135 | 0.00000125 | 0.00000884 | 0.00000323 | 116 | RABC92 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 91/6806 | 92/8135 | 0.0000013 | 0.00000884 | 0.00000323 | 91 | RABC92 | |
| KEGG | hsa05222 | Small cell lung cancer | 91/6806 | 92/8135 | 0.0000013 | 0.00000884 | 0.00000323 | 91 | RABC92 | |
| KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 200/6806 | 212/8135 | 0.00000163 | 0.0000109 | 0.00000397 | 200 | RABC92 | |
| KEGG | hsa04261 | Adrenergic signaling in cardiomyocytes | 144/6806 | 150/8135 | 0.00000204 | 0.0000134 | 0.00000488 | 144 | RABC92 | |
| KEGG | hsa04727 | GABAergic synapse | 88/6806 | 89/8135 | 0.00000216 | 0.0000136 | 0.00000497 | 88 | RABC92 | |
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 88/6806 | 89/8135 | 0.00000216 | 0.0000136 | 0.00000497 | 88 | RABC92 |